MARKET

NKTX

NKTX

Nkarta, Inc.
NASDAQ
2.330
+0.080
+3.56%
Opening 09:49 04/08 EDT
OPEN
2.400
PREV CLOSE
2.250
HIGH
2.400
LOW
2.310
VOLUME
63.63K
TURNOVER
--
52 WEEK HIGH
2.810
52 WEEK LOW
1.420
MARKET CAP
166.11M
P/E (TTM)
-1.6564
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NKTX last week (0330-0403)?
Weekly Report · 2d ago
Nkarta Is Maintained at Outperform by Mizuho
Dow Jones · 03/31 13:33
Nkarta Price Target Cut to $12.00/Share From $14.00 by Mizuho
Dow Jones · 03/31 13:33
Mizuho Maintains Outperform on Nkarta, Lowers Price Target to $12
Benzinga · 03/31 13:23
Nkarta price target lowered to $12 from $14 at Mizuho
TipRanks · 03/31 11:08
Weekly Report: what happened at NKTX last week (0323-0327)?
Weekly Report · 03/30 10:28
Analysts Are Bullish on Top Healthcare Stocks: Nkarta (NKTX), BioCardia (BCDA)
TipRanks · 03/28 05:20
Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and Nkarta (NKTX)
TipRanks · 03/28 05:00
More
About NKTX
Nkarta, Inc. is a clinical-stage biopharmaceutical company advancing the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is developing NKX019, a chimeric antigen receptor-natural killer (CAR NK) product candidate targeting the CD19 antigen for the treatment of patients with autoimmune diseases and NKX101, a CAR NK product candidate targeting cells that display NKG2D ligands. NKX019 is engineered with a humanized CD19-directed CAR for enhanced cell targeting and a proprietary, membrane-bound form of interleukin-15 (IL-15) for greater persistence and activity without exogenous cytokine support. CD19 is a biomarker for normal B cells as well as those implicated in autoimmune disease and B cell-derived malignancies. Its NKX019 autoimmune program is based on the potential to eliminate the pathologic B cells that produce autoantibodies.

Webull offers Nkarta Inc stock information, including NASDAQ: NKTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NKTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NKTX stock methods without spending real money on the virtual paper trading platform.